secwatch / observer
8-K filed June 9, 2026, 4:31 PM ET ticker ETON CIK 0001710340
other confidence high sentiment neutral materiality 0.00

Eton Pharmaceuticals reports stockholder voting results from 2026 annual meeting

Eton Pharmaceuticals, Inc.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Eton Pharmaceuticals, Inc. shareholders voted on Election of Directors at the 2026-06-09 meeting.

Proposal
director election
Meeting
2026-06-09
Exact text from the filing
Proposal 1: Election of Directors Nominee For Withheld Broker Non-Votes Jenn Adams 13,370,948 2,149,317 4,664,035 Charles J. Casamento 9,925,548 5,594,717 4,664,035
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Eton Pharmaceuticals, Inc. shareholders approved Ratification of the Appointment of Grant Thornton LLP as the Company's Independent Registered Public Accounting Firm for the year ending December 31, 2026 at the 2026-06-09 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-06-09
Exact text from the filing
Proposal 2: Ratification of the Appointment of Grant Thornton LLP as the Company ’ s Independent Registered Public Accounting Firm for the year ending December 31, 2026 For Against Abstain 16,942,328 3,236,671 5,301
View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Eton Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR
accession 0001437749-26-020005
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.